Physician profile
William A Pitt
NPI 1861544850
$1,132.42
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $68.84 · 2021: $214 · 2022: $249 · 2023: $356 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $213.63 | 2021-2023 | |
| Gilead Sciences, INC. | $119.40 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $67.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.95 | 2022 | |
| Abbott Laboratories | $64.98 | 2019-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Biotronik INC. | $58.30 | 2019-2024 | Acticor 7 Vr-T Dx, Biomonitor, Rivacor 7 Dr-T |
| Novo Nordisk INC | $52.73 | 2021-2024 | Saxenda, Wegovy, Ozempic |
| Exact Sciences Corporation | $51.40 | 2023 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $51.05 | 2022-2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.04 | 2022 | |
| Pfizer INC. | $38.50 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $36.33 | 2019-2020 | |
| Irhythm Technologies, INC. | $33.71 | 2020-2023 | Zio Xt Patch |
| Lilly USA, LLC | $30.19 | 2023 | Mounjaro, Trulicity |
| Astrazeneca Pharmaceuticals LP | $29.44 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.87 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.39 | 2021 | |
| Medtronic, INC. | $20.35 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.10 | 2022 | |
| Medtronic Vascular, INC. | $20.01 | 2020 | |
| Baxter Healthcare | $19.94 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Biohaven Pharmaceutical Holding Company LTD. | $19.53 | 2022 | |
| Amarin Pharma, INC. | $16.60 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Pitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.